Kadoma, Japan

Nobumitsu Nakahasi

This inventor holds 1 USPTO granted patent. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nobumitsu Nakahasi. Retrieved from https://idiyas.com/inventor/nobumitsu-nakahasi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nobumitsu Nakahasi: Innovator in Pharmaceutical Composition

Introduction

Nobumitsu Nakahasi is a notable inventor based in Kadoma, Japan. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on drug compositions. His expertise and dedication have led to advancements that enhance the effectiveness of pharmaceutical products.

Latest Patents

Nakahasi holds a patent for a novel pharmaceutical composition comprising exifone and water-soluble cellulose derivatives. This composition is a physical mixture that exhibits surprisingly improved solubility and bioavailability. The patent highlights the potential for enhanced therapeutic effects, making it a valuable addition to the pharmaceutical industry.

Career Highlights

Nobumitsu Nakahasi is associated with Fujisawa Pharmaceutical Company, Ltd., where he has been instrumental in developing new pharmaceutical solutions. His work has not only contributed to the company's portfolio but has also impacted the broader field of medicine.

Collaborations

Throughout his career, Nakahasi has collaborated with esteemed colleagues such as Yoshio Uedo and Fumio Shimojo. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Nobumitsu Nakahasi's contributions to pharmaceutical compositions demonstrate his commitment to improving drug efficacy. His innovative spirit and collaborative efforts continue to influence the pharmaceutical landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…